Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas - PubMed (original) (raw)

Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas

Y Imai et al. Jpn J Cancer Res. 1996 Oct.

Abstract

Because combined hepatocellular-cholangiocellular carcinoma is rare and its biological features and pathogenesis have not been well established, we investigated alterations of the p53, K-ras and Rb-1 genes, as well as expression patterns of carcinoembryonic antigen and keratin, in seven combined hepatocellular-cholangiocarcinomas out of 557 hepatocellular carcinomas autopsied at Tokyo University during 30 years. Mutations of the p53 gene were found in two cases, at codon 244 (GGC to TGC) in the cholangiocellular carcinoma component of case 1 (mixed type, showing an intimate intermingling of both elements) and at codon 234 (TAC to AAC) in both components of case 5 (combined type, consisting of contiguous but independent masses of both elements). Mutation of the K-ras gene (codon 12, GGT to GAT) was seen only in the cholangiocellular carcinoma component of clinically apparent double cancer, case 6. Allelic alteration of the Rb-1 gene was observed in two cases, deletion of both alleles in the hepatocellular carcinoma component of case 3 (combined type) and replication error of the same pattern in both components of case 4 (mixed type). Immunohistochemical analysis showed that the hepatocellular carcinoma components of five cases (cases 2, 3, 5, 6, 7) were immunoreactive for keratin, suggesting biliary epithelial transformation. In four of the five cases (cases 3 and 5 combined, case 7 mixed and case 6 double cancer), cholangiocellular carcinoma components were also positive for keratin. These results suggest that both components of combined hepatocellular-cholangiocarcinoma have the same genetic and phenotypic character and might have arisen from the same origin in some cases.

PubMed Disclaimer

Cited by

Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.
Wang J, Li E, Yang H, Wu J, Lu HC, Yi C, Lei J, Liao W, Wu L. Wang J, et al. World J Surg Oncol. 2019 Feb 27;17(1):43. doi: 10.1186/s12957-019-1586-8. World J Surg Oncol. 2019. PMID: 30813932 Free PMC article.
A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.
Mok SR, Mohan S, Grewal N, Elfant AB, Judge TA. Mok SR, et al. J Gastrointest Oncol. 2016 Aug;7(4):570-9. doi: 10.21037/jgo.2016.04.01. J Gastrointest Oncol. 2016. PMID: 27563447 Free PMC article.
Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
Wang AQ, Zheng YC, Du J, Zhu CP, Huang HC, Wang SS, Wu LC, Wan XS, Zhang HH, Miao RY, Sang XT, Zhao HT. Wang AQ, et al. World J Gastroenterol. 2016 May 14;22(18):4459-65. doi: 10.3748/wjg.v22.i18.4459. World J Gastroenterol. 2016. PMID: 27182157 Free PMC article. Review.
Genetic profiling of intrahepatic cholangiocarcinoma.
Andersen JB, Thorgeirsson SS. Andersen JB, et al. Curr Opin Gastroenterol. 2012 May;28(3):266-72. doi: 10.1097/MOG.0b013e3283523c7e. Curr Opin Gastroenterol. 2012. PMID: 22395571 Free PMC article. Review.
Synchronous development of HCC and CCC in the same subsegment of the liver in a patient with type C liver cirrhosis.
Watanabe T, Sakata J, Ishikawa T, Shirai Y, Suda T, Hirono H, Hasegawa K, Soga K, Shibasaki K, Saito Y, Umezu H. Watanabe T, et al. World J Hepatol. 2009 Oct 31;1(1):103-9. doi: 10.4254/wjh.v1.i1.103. World J Hepatol. 2009. PMID: 21160972 Free PMC article.

References

1. ) Aoki , K. , Takayasu , K. , Kawano , T. , Muramatsu , Y. , Moriyama , N. , Wakao , F. , Yamamoto , J. , Shimada , K. , Takayama , T. , Kosuge , T. , Yamasaki , S. , Sakamoto , M. and Hirohashi , S.Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings . Hepatology , 18 , 1090 – 1095 ( 1993. ). - PubMed
1. ) Edmondson , H. A. and Peters , R. L.Neoplasms of the liver . In“Diseases of the Liver, 5th Ed.,” ed. Schiff L. , Schiff E. R. , p. 1101 ( 1982. ). J. B. Lippincott; , Philadelphia .
1. ) Nakahara , T.A clinicopathological study of combined hepatocellular‐cholangiocellular carcinoma . Acta Hepatol. Jpn. , 27 , 1431 – 1438 ( 1986. ).
1. ) Tobe , R. , Okuda , K. , Sasaki , H. , Shikata , T. , Sugawara , K. , Totsuki , T. , Nakajima , T. , Hattori , S. , Mizumoto , R. and Mori , W.The 8th report . Acta Hepatol. Jpn. , 29 , 1619 – 1626 ( 1988. ).
1. ) Uekusa , T.A immunohistochemical study of combined hepatocellular‐cholangiocellular carcinoma . Acta Hepatol. Jpn. , 27 , 343 – 353 ( 1987. ).

Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas - PubMed (original) (raw)